M4 mAChR agonist-1(Cat No.:I043538)is a selective compound that targets the M4 muscarinic acetylcholine receptor (mAChR), a G-protein coupled receptor involved in the modulation of central nervous system (CNS) functions. By selectively activating the M4 receptor, this agonist modulates neurotransmitter release, with potential therapeutic applications in neurodegenerative diseases like Parkinson’s and schizophrenia. Its ability to enhance cholinergic signaling in the brain may help address motor and cognitive deficits associated with these conditions. M4 mAChR agonist-1 serves as a promising candidate for advancing treatments aimed at restoring neural balance in CNS disorders.